496 related articles for article (PubMed ID: 19778945)
21. D-dimer before chemotherapy might predict venous thromboembolism.
Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels.
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Seifried E; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):524-34. PubMed ID: 19620844
[TBL] [Abstract][Full Text] [Related]
23. Identifying cancer patients at risk for venous thromboembolism.
Sousou T; Khorana A
Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism in ovarian cancer.
Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
[TBL] [Abstract][Full Text] [Related]
27. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
[TBL] [Abstract][Full Text] [Related]
28. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
[TBL] [Abstract][Full Text] [Related]
29. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
[TBL] [Abstract][Full Text] [Related]
32. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
33. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism.
O'Donnell J; Laffan M
Clin Lab; 2001; 47(1-2):1-6. PubMed ID: 11214218
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.
Stassen PM; Derks RP; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2008 Apr; 47(4):530-4. PubMed ID: 18356178
[TBL] [Abstract][Full Text] [Related]
35. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
[TBL] [Abstract][Full Text] [Related]
36. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
37. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
Nossent AY; Eikenboom JC; Vos HL; Bakker E; Tanis BC; Doggen CJ; Bertina RM; Rosendaal FR
Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372
[TBL] [Abstract][Full Text] [Related]
38. High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly.
Oger E; Lacut K; Van Dreden P; Bressollette L; Abgrall JF; Blouch MT; Scarabin PY; Mottier D
Haematologica; 2003 Apr; 88(4):465-9. PubMed ID: 12681975
[TBL] [Abstract][Full Text] [Related]
39. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
40. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
